Wednesday, October 20, 2021 8:52:28 AM
Yup. I was thinking the exact same thing.
LORENZO'S OIL is the remarkable true story of a Christian couple's faith in God as they battle against time and the medical establishment to save their son's life. LORENZO'S OIL is emotionally intense and a powerful testimony to the power of prayer and faith in God. The mother and father's love for the child serves as a model of perseverance.
BASED ON a true story, LORENZO’S OIL tells about Lorenzo Odone, a 9-year-old boy who is struck down by a rare disease called Adrenoleukodystrophy (ALD), which causes degeneration of the brain. ALD is a genetic disorder carried down from mother to male offspring. Because of ALD, Lorenzo does not have the ability to produce a certain enzyme that keeps fat from building up in his blood. Consequently, Lorenzo degenerates from a healthy, active boy into a withered, frail, hairless child who can’t walk, talk, swallow, or see, and he suffers from seizures that cause him to tremble, scream and choke. His faithful and determined parents Augusto (Nick Nolte) and Michaela (Susan Sarandon) Odone begin conducting their own research. The couple discover an antidote, a medicinal oil. When Lorenzo adds this oil to his diet, it stabilizes the fat in his blood. By 14, he is able to see and communicate with simple sounds. The oil is coined LORENZO’S OIL and is now given to boys suffering from ALD.
LORENZO'S OIL is the remarkable true story of a Christian couple's faith in God as they battle against time and the medical establishment to save their son's life. LORENZO'S OIL is emotionally intense and a powerful testimony to the power of prayer and faith in God. The mother and father's love for the child serves as a model of perseverance.
BASED ON a true story, LORENZO’S OIL tells about Lorenzo Odone, a 9-year-old boy who is struck down by a rare disease called Adrenoleukodystrophy (ALD), which causes degeneration of the brain. ALD is a genetic disorder carried down from mother to male offspring. Because of ALD, Lorenzo does not have the ability to produce a certain enzyme that keeps fat from building up in his blood. Consequently, Lorenzo degenerates from a healthy, active boy into a withered, frail, hairless child who can’t walk, talk, swallow, or see, and he suffers from seizures that cause him to tremble, scream and choke. His faithful and determined parents Augusto (Nick Nolte) and Michaela (Susan Sarandon) Odone begin conducting their own research. The couple discover an antidote, a medicinal oil. When Lorenzo adds this oil to his diet, it stabilizes the fat in his blood. By 14, he is able to see and communicate with simple sounds. The oil is coined LORENZO’S OIL and is now given to boys suffering from ALD.
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
